Position in DGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,482
-$841,501 QoQ
Shares Held
191
-96.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#917
of 1,090 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Neo Ivy Capital Management holds $2,509,451 across 5 Diagnostics & Research names. DGX ranks #4 (1.6% of the industry book) .
All Filings in DGX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,482 | 191 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $881,983 | 4,910 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $3,723,375 | 24,681 | Shares | Sole | 2025-02-18 | |
| 2023-09-30 | $658,531 | 5,404 | Shares | Sole | 2023-11-30 | |
| 2022-09-30 | $2,453 | 20 | Shares | Sole | 2022-11-16 | |
| 2022-03-31 | $63,229 | 462 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $27,508 | 159 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $173,790 | 1,196 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $5,646 | 44 | Shares | Sole | 2021-10-07 | |
| 2020-12-31 | $585,720 | 4,915 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $23,126 | 202 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $136,296 | 1,196 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $156,504 | 1,949 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||